| # | Drug | Count |
|---|---|---|
| 0 | QUETIAPINE | 317 |
| 1 | CITALOPRAM | 250 |
| 2 | CITALOPRAM HYDROBROMIDE | 245 |
| 3 | CLONAZEPAM | 220 |
| 4 | RISPERIDONE | 218 |
| 5 | SERTRALINE | 189 |
| 6 | ARIPIPRAZOLE | 175 |
| 7 | ESCITALOPRAM | 164 |
| 8 | RITONAVIR | 156 |
| 9 | ATAZANAVIR | 152 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BUPROPION HYDROBROMIDE | 19 | 0.0329 |
| 1 | DIBUCAINE 1% | 2 | 0.0174 |
| 2 | MEFLOQUINE HYDROCHLORIDE | 2 | 0.0128 |
| 3 | BETAMETHASONE VALERATE FOAM | 58 | 0.0126 |
| 4 | LULICONAZOLE | 2 | 0.0114 |
| 5 | CAPSICUM ANNUUM, FUCUS VESICULOSUS, BORAGE OFFICINALIS, LECITHIN, CALCAREA CARBONICA, FERRUM METALLICUM, KALI BICHROMICUM, KALI CARBONICA, PULSATILLA (PRATENSIS), SULPHUR | 1 | 0.0114 |
| 6 | ATAZANAVIR | 152 | 0.0106 |
| 7 | BULEVIRTIDE | 1 | 0.0104 |
| 8 | RITONAVIR 100 MG | 131 | 0.0088 |
| 9 | LOPINAVIR AND RITONAVIR | 117 | 0.0087 |
| # | Drug class | Count |
|---|---|---|
| 0 | Atypical Antipsychotic [EPC] | 626 |
| 1 | Benzodiazepine [EPC] | 428 |
| 2 | Mood Stabilizer [EPC] | 322 |
| 3 | Anti-epileptic Agent [EPC] | 311 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 299 |
| 5 | Corticosteroid [EPC] | 253 |
| 6 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 181 |
| 7 | Serotonin Reuptake Inhibitor [EPC] | 178 |
| 8 | Cytochrome P450 3A Inhibitor [EPC] | 158 |
| 9 | Protease Inhibitor [EPC] | 158 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 63 | 0.0916 |
| 1 | Catecholamine Synthesis Inhibitor [EPC] | 1 | 0.0123 |
| 2 | Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator [EPC] | 8 | 0.0041 |
| 3 | Protease Inhibitor [EPC] | 158 | 0.0036 |
| 4 | Guanylate Cyclase-C Agonist [EPC] | 7 | 0.0034 |
| 5 | Nitrofuran Antibacterial [EPC] | 59 | 0.0034 |
| 6 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 145 | 0.0030 |
| 7 | Cytochrome P450 3A Inhibitor [EPC] | 158 | 0.0026 |
| 8 | Vesicular Monoamine Transporter 2 Inhibitor [EPC] | 3 | 0.0024 |
| 9 | CD19-directed Cytolytic Antibody [EPC] | 2 | 0.0023 |